Trusted Resources: Education
Scientific literature and patient education texts
Nutritional, Gastrointestinal and Endo-Metabolic Challenges in The Management of Children with Spinal Muscular Atrophy Type 1
source: Nutrients
year: 2021
authors: Antonio Corsello, Lorenzo Scatigno, Martina Chiara Pascuzzi, Valeria Calcaterra, Dario Dilillo, Sara Vizzuso, Gloria Pelizzo, et al.
summary/abstract:The management of patients with spinal muscular atrophy type 1 (SMA1) is constantly evolving. In just a few decades, the medical approach has switched from an exclusively palliative therapy to targeted therapy, transforming the natural history of the disease, improving survival time and quality of life, and creating new challenges and goals. Many nutritional problems, gastrointestinal disorders, and metabolic and endocrine alterations are commonly identified in patients affected by SMA1 during childhood and adolescence. For this reason, a proper pediatric multidisciplinary approach is then required in the clinical care of these patients, with a specific focus on the prevention of the most common complications. The purpose of this narrative review is to provide the clinician with a practical and usable tool for SMA1 patients’ care, through a comprehensive insight into the nutritional, gastroenterological, metabolic, and endocrine management of SMA1. Considering the possible horizons opened thanks to new therapeutic frontiers, nutritional and endo-metabolic surveillance is a crucial element to be considered for proper clinical care of these patients.
organization: University of Milan, Italy; University of Pavia, Italy; Children’s Hospital Vittore Buzzi, Milan, Italy; “Aldo Moro” University of Bari, Italy; University of Foggia, Italy
DOI: 10.3390/nu13072400
read more
Related Content
-
Comparative All-Cause Mortality Among a Large Population of Patients With Spinal Muscular Atrophy Versus Matched Con...Introduction: There is little informatio...
-
Detection of Spinal Muscular Atrophy Patients Using Dried Saliva SpotsSpinal muscular atrophy (SMA) is a lower...
-
SMA Angels Charity – Facebook100% Volunteer, 501 (c)(3) non-profit de...
-
Biogen Exercises Option With Ionis to Develop and Commercialize Investigational ASO for SMABiogen, Inc. and Ionis Pharmaceuticals, ...
-
STR1VE-EU Trial Shows Efficacy of Onasemnogene Abeparvovec in Spinal Muscular AtrophyOnasemnogene abeparvovec gene replacemen...
-
Gene Therapy for SMA Type 1: Evelyn’s Storyhttps://www.youtube.com/watch?v=yRrqbvUv...
-
Your Guide to Spinal Muscular Atrophyhttps://simedhealth.com/sites/default/fi...